Rafferty Asset Management, LLC Homology Medicines, Inc. Transaction History

Rafferty Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$6.02 - $9.64 $2.75 Million - $4.41 Million	-457,593 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$9.17 - $14.8 $3.59 Million - $5.79 Million	391,522 Added 592.58%	457,593 $4.31 Million
Q4 2020 Feb 10, 2021	BUY	$8.92 - $13.29 $589,353 - $878,083	66,071 New	66,071 $746,000
Q3 2020 Nov 13, 2020	SELL	$9.94 - $16.59 $141,307 - $235,843	-14,216 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$12.07 - $19.34 $171,587 - $274,937	14,216 New	14,216 $216,000

Q1 2020 May 15, 2020	SELL	$12.5 - $22.04 $218,162 - $384,664	-17,453 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$11.42 - $22.19 $211,635 - $411,225	-18,532 Reduced 51.5%	17,453 $361,000
Q3 2019 Nov 14, 2019	SELL	$14.74 - $22.28 $34,196 - $51,689	-2,320 Reduced 6.06%	35,985 $651,000
Q2 2019 Aug 09, 2019	BUY	$18.35 - $30.34 $702,896 - $1.16 Million	38,305 New	38,305 $750,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.